Edanz Evidence Generation Landscape and Gap analyses Evidence maps Systematic Literature Reviews Publication planning Congress materials Article development Physician & Patient surveys
Gap and Landscape Analysis Reports
We develop customized reports to support your decision making. Edanz has extensive expertise in searching, analyzing, summarizing, and interpreting the published literature.
Our reports provide a systematic approach to building an evidence generation strategy for your product:
- Literature reviews and analysis
- Opportunities analysis
- Research question identification
- Gap & Situation analysis
- Unmet clinical needs
- Key factors underlying competitor product success
- Competitor product evidence maps
- Publication plans
- Future trial suggestions: endpoints, (sub-)analyses, populations of interest, recruitment
Our reports are tailored to your needs so get in touch to discuss report scope and depth. See our process here.
Working time: 15–30 days once project scope is established (excluding client review time)
Manuscript development
Starting from a clinical study report, data tables and/or notes, we develop a high-quality manuscript for publication. Our medical writing process includes journal recommendation reports, therapeutic area expert review, five rounds of client review at key steps, journal submission documentation, and all post-peer review response and revisions.
- Original articles (at all stages of drug development)
- Clinical trial reports
- Medical device studies
- Reviews
- Systematic reviews & Meta analyses and
- Encore articles
Get in touch for a project team, plan and quote. See our process here.
Working time: 40–45 business days (excluding client review time)
About Edanz Evidence Generation
Edanz Evidence Generation provides high-quality evidence generation services in all major therapeutic areas, with particular strengths in endocrinology, neurology and oncology. Edanz was founded in Japan in 1995, and has been providing high quality and cost effective medical and scientific editing, rewriting and publication guidance to the academic and research communities ever since. Edanz joined M3 Group (Tokyo Stock Exchange First Section -securities code 2413) in 2019.
We have a team of international experts with vast industry and medical writing experience. Unlike many other agencies, we are completely transparent about the people in our teams.
*Since May 2020, the Edanz’s medical communications business is known as “Edanz Evidence Generation”.
Koji Yamashita
Director & CEO
Koji Yamashita joined Edanz in January 2016 as Group CEO and board member. Koji joined Edanz from SpringerNature where he was Japan President and Managing Director as well as the APAC Regional Sales Director for Springer Healthcare, a leading global provider of medical communications services. Koji has a wealth of experience in the medical communications and publication industry.
Tom da Costa
Director
Tom da Costa graduated from the University of Oxford in 2000 where he specialized in ancient languages. His international career includes positions in the city of London, Sydney and Japan. Tom oversees the medical writing division, and is a member of the Edanz Group management team.
Tom is a member of ISMPP.
Daniel McGowan, PhD, CMPP
Director
Dr Daniel McGowan, PhD Molecular Neuroscience, was an Associate Editor of Nature Reviews Neuroscience, before joining the Edanz Group in 2006. Prior to working in the publishing industry, Dr McGowan was a Senior Scientist at the University of Cambridge, UK and a Marie Curie Research Fellow at the Babraham Institute, also in Cambridge. He has more than ten years of post-doctoral and post-graduate laboratory experience in the areas of neurodegenerative diseases, molecular and cellular biology, protein biochemistry, proteomics and genomics.
Daniel is a member of ISMPP and is a Certified Medical Publications Professional.
Rigorous ethical standards
All Edanz Group companies operate under rigorous ethical and quality control standards, ensure complete confidentiality and non-disclosure, and only use highly trained scientific and medical communicators. Edanz strictly adheres to international guidelines regarding medical writing best practice, including GPP3, ISMPP, EMWA, ICMJE guidelines.
